Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,058 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Lotilaner Ophthalmic Solution 0.25% for Demodex Blepharitis: Randomized, Vehicle-Controlled, Multicenter, Phase 3 Trial (Saturn-2).
Gaddie IB, Donnenfeld ED, Karpecki P, Vollmer P, Berdy GJ, Peterson JD, Simmons B, Edell ARP, Whitson WE, Ciolino JB, Baba SN, Holdbrook M, Trevejo J, Meyer J, Yeu E; Saturn-2 Study Group. Gaddie IB, et al. Among authors: simmons b. Ophthalmology. 2023 Oct;130(10):1015-1023. doi: 10.1016/j.ophtha.2023.05.030. Epub 2023 Jun 5. Ophthalmology. 2023. PMID: 37285925 Free article. Clinical Trial.
The impact of Demodex blepharitis on patient symptoms and daily life.
Barnett M, Simmons B, Vollmer P, Patel A, Whitson WE, Berdy GJ, Karpecki P, Periman LM, Holdbrook M, Baba SN, Meyer J, Yeu E. Barnett M, et al. Among authors: simmons b. Optom Vis Sci. 2024 Mar 1;101(3):151-156. doi: 10.1097/OPX.0000000000002111. Epub 2024 Feb 7. Optom Vis Sci. 2024. PMID: 38546756 Free PMC article.
Safety and Efficacy of Lotilaner Ophthalmic Solution (0.25%) in Treating Demodex Blepharitis: Pooled Analysis of Two Pivotal Trials.
Yeu E, Paauw JD, Vollmer P, Berdy GJ, Whitson WE, Meyer J, Simmons B, Peterson JD, Periman LM, Boehmer BE, Bloomenstein MR, Whitley WO, Koetting C, Dhamdhere K, Neervannan S, Ciolino JB. Yeu E, et al. Among authors: simmons b. Ophthalmol Ther. 2025 Mar;14(3):555-571. doi: 10.1007/s40123-024-01089-5. Epub 2025 Jan 28. Ophthalmol Ther. 2025. PMID: 39873946 Free PMC article.
Offshore wind farms act as de facto marine reserves.
Fitkov-Norris B, Witt MJ, Simmons BI. Fitkov-Norris B, et al. Among authors: simmons bi. Sci Total Environ. 2025 Jul 7;994:179973. doi: 10.1016/j.scitotenv.2025.179973. Online ahead of print. Sci Total Environ. 2025. PMID: 40628155 Free article.
Fast growth and high-titer bioproduction from renewable formate via metal-dependent formate dehydrogenase in Escherichia coli.
Cowan AE, Hillers M, Rainaldi V, Collas F, Choudhary H, Zakaria BS, Bieberach GG, Carruthers DN, Grabovac M, Gin JW, Cawthon B, Chen Y, Turumtay EA, Baidoo EEK, Petzold CJ, Feist AM, Tejedor-Sanz S, Kensy F, Simmons BA, Keasling JD, Claassens NJ. Cowan AE, et al. Among authors: simmons ba. Nat Commun. 2025 Jul 1;16(1):5908. doi: 10.1038/s41467-025-61001-y. Nat Commun. 2025. PMID: 40593698 Free PMC article.
Recent Advances in the Use of Ionic Liquids and Deep Eutectic Solvents for Lignocellulosic Biorefineries and Biobased Chemical and Material Production.
Verdía Barbará P, Choudhary H, Nakasu PS, Al-Ghatta A, Han Y, Hopson C, Aravena RI, Mishra DK, Ovejero-Pérez A, Simmons BA, Hallett JP. Verdía Barbará P, et al. Among authors: simmons ba. Chem Rev. 2025 Jun 25;125(12):5461-5583. doi: 10.1021/acs.chemrev.4c00754. Epub 2025 Jun 6. Chem Rev. 2025. PMID: 40479538 Free PMC article. Review.
1,058 results